Inventor · disambiguated record
Devron R. Averett
Also filed as: AVERETT DEVRON · AVERETT DEVRON R · AVERETT DEVRON RANDOLPH
30 granted patents·8 pending applications·1,229 citations·filing 1987–2016
98Inventor score
Files withANADYS PHARMACEUTICALS INC8ICN PHARMACEUTICALS7AVERETT DEVRON R4WELL Shield LLC4AVERETT STEWART BENSON3
Top patents by PatentIndex Score
38 records- 0198US6573248B2Monocyclic L-nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 2001·Granted Jun 3, 2003·179 cites·10 claims
- 0297US8034802B2Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virusANADYS PHARMACEUTICALS INC·Filed 2009·Granted Oct 11, 2011·43 cites·33 claims
- 0397US7576068B2Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virusANADYS PHARMACEUTICALS INC·Filed 2004·Granted Aug 18, 2009·91 cites·20 claims
- 0497US6924271B23-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2002·Granted Aug 2, 2005·123 cites·10 claims
- 0597US6479463B1Purine L-nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 2000·Granted Nov 12, 2002·123 cites·5 claims
- 0696US6642206B2Monocyclic L-nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 2002·Granted Nov 4, 2003·102 cites·5 claims
- 0796US6130326AMonocyclic L-Nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 1999·Granted Oct 10, 2000·139 cites·4 claims
- 0895US9144242B2Titanium dioxide photocatalytic compositions and uses thereofAVERETT STEWART BENSON·Filed 2013·Granted Sep 29, 2015·16 cites·7 claims
- 0995US8609121B2Titanium dioxide photocatalytic compositions and uses thereofAVERETT STEWART B·Filed 2012·Granted Dec 17, 2013·28 cites·5 claims
- 1095US6552183B1Moncyclic L-nucleosides analogsICN PHARMACEUTICALS·Filed 2000·Granted Apr 22, 2003·74 cites·2 claims
- 1195US6509320B1Purine L-nucleosides, analogs and uses thereofICN PHARMACEUTICALS·Filed 2000·Granted Jan 21, 2003·83 cites·3 claims
- 1294US9392795B2Titanium dioxide photocatalytic compositions and uses thereofWELL Shield LLC·Filed 2015·Granted Jul 19, 2016·7 cites·15 claims
- 1394US9055751B2Titanium dioxide photocatalytic compositions and uses thereofAVERETT STEWART BENSON·Filed 2013·Granted Jun 16, 2015·11 cites·11 claims
- 1493US6455690B1L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosineFiled 2000·Granted Sep 24, 2002·49 cites·1 claims
- 1591US8211863B2Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virusAVERETT DEVRON R·Filed 2011·Granted Jul 3, 2012·14 cites·35 claims
- 1689US7858637B2Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virusAVERETT DEVRON R·Filed 2009·Granted Dec 28, 2010·10 cites·35 claims
- 1785US7745415B23-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2008·Granted Jun 29, 2010·6 cites·12 claims
- 1881US9833003B2Titanium dioxide photocatalytic compositions and uses thereofWELL Shield LLC·Filed 2016·Granted Dec 5, 2017·1 cites·20 claims
- 1980US10434203B2Reduction of infections in healthcare settings using photocatalytic compositionsWELL Shield LLC·Filed 2016·Granted Oct 8, 2019·2 cites·18 claims
- 2079US9402400B2Titanium dioxide photocatalytic compositions and uses thereofAVERETT STEWART BENSON·Filed 2015·Granted Aug 2, 2016·1 cites·8 claims
- 2179US7943759B23-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2010·Granted May 17, 2011·3 cites·6 claims
- 2276US7321033B23-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2004·Granted Jan 22, 2008·7 cites·11 claims
- 2375US6423695B1Cytokine related treatments of diseaseRIBAPHARM INC·Filed 1999·Granted Jul 23, 2002·34 cites·12 claims
- 2474US5492897AMethod for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivativesBURROUGHS WELLCOME CO 141·Filed 1994·Granted Feb 20, 1996·26 cites·4 claims
- 2572US5821236ATumor treatment with arabinofuranosyl purine derivativesGLAXO WELLCOME INC·Filed 1995·Granted Oct 13, 1998·23 cites·4 claims
- 2661US2005182001A13-beta-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2761US2003207826A1Cytokine related treatments of diseaseFiled 2003·Application pending·0 cites
- 2858US2008090844A13-beta-D-Ribofuranosylthiazalo [4-5-d] pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2958US2002132784A1Cytokine related treatments of diseaseFiled 2002·Application pending·0 cites
- 3053US6613896B1Method of producing tiazofurin and other C-nucleosidesICN PHARMACEUTICALS·Filed 1998·Granted Sep 2, 2003·9 cites·21 claims
- 3150US5393883AAntiviral combinations and compounds thereforBURROUGHS WELLCOME CO·Filed 1992·Granted Feb 28, 1995·6 cites·6 claims
- 3249US2015367007A1Reduction of infections in healthcare settings using photocatalytic compositionsWELL Shield LLC·Filed 2015·Application pending·0 cites
- 3349US2006052346A1Nucleoside phosphonate derivatives useful in the treatment of HIV infectionsAVERETT DEVRON R·Filed 2005·Application pending·0 cites
- 3448US5747472ATherapeutic methods for using ARA-G derivativesGLAXO WELLCOME INC·Filed 1995·Granted May 5, 1998·5 cites·11 claims
- 3547US4758572AAntiviral combinationsBURROUGHS WELLCOME CO·Filed 1987·Granted Jul 19, 1988·12 cites·6 claims
- 3645US2008070852A13-Beta-D-Ribofuranosylthiazolo[ 4,5-D] Pyridimine Nucleosides and Uses ThereofAVERETT DEVRON R·Filed 2004·Application pending·0 cites
- 3744US5175165AAntiviral combinations and compounds thereforBURROUGHS WELLCOME CO·Filed 1989·Granted Dec 29, 1992·2 cites·1 claims
- 3841US2002058635A1Purine L-nucleosides, analogs and uses thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Devron R. Averett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →